In turn, HDAC inhibitors facilitated an increase of PGC1A, which facilitated enhanced oxygen consumption rate and drove survival of GBM cells since knock-down of PGC1A abrogated these effects [44]. Here, PPARGC1A is linked to glioblastoma.